Back

New RDEB intermediate variant with in-frame partial exon skipping in FN-III-like domain of type VII collagen.

Evtushenko, N.; Kubanov, A.; Martynova, A.; Kondratyev, N.; Beilin, A.; Karamova, A.; Monchakovskaya, E.; Azimov, K.; Nefedova, M.; Bozhanova, N.; Zaklyazminskaya, E.; Gurskaya, N.

2022-09-04 dermatology
10.1101/2022.09.02.22278356 medRxiv
Show abstract

Recessive Dystrophic Epidermolysis Bullosa (RDEB) is a debilitating genodermatosis caused by pathogenic mutations in the COL7A1 gene, which induce absence or reduction in the number of anchoring fibrils. The severity of RDEB depends on the mutation type and localization, but many aspects of this dependence remain to be elucidated. Here, we report a novel variant of RDEB Intermediate in two unrelated patients. Their disease manifestation includes early skin and oral mucosa blistering and is associated with localized atrophic scarring. According to the exome and Sanger sequencing results, both investigated Probands are the carriers of complex heterozygosity in the COL7A1 gene with the same deletion in intron 19 of the COL7A1 gene. RT-PCR followed by sequence analysis revealed skipping of the part of exon19, as well as the rescue of the open reading frame (ORF) of COL7A1 in both Probands. We hypothesize that the mutation in the acceptor splice site leads to the activation of the cryptic donor splice site, resulting in the truncated but partially functional protein and the milder phenotype of intermediate RDEB. This rare type of mutation expands our understanding of RDEB etiology and invites further investigation.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Human Genomics
21 papers in training set
Top 0.1%
17.5%
2
Matrix Biology
28 papers in training set
Top 0.1%
10.4%
3
Journal of Investigative Dermatology
42 papers in training set
Top 0.1%
10.1%
4
Human Mutation
29 papers in training set
Top 0.1%
6.3%
5
Frontiers in Medicine
113 papers in training set
Top 0.8%
4.8%
6
Journal of Advanced Research
15 papers in training set
Top 0.1%
4.8%
50% of probability mass above
7
Scientific Reports
3102 papers in training set
Top 28%
4.3%
8
eLife
5422 papers in training set
Top 26%
3.6%
9
Frontiers in Immunology
586 papers in training set
Top 2%
3.6%
10
Blood Advances
54 papers in training set
Top 0.4%
3.6%
11
Experimental Dermatology
10 papers in training set
Top 0.1%
2.6%
12
Pigment Cell & Melanoma Research
11 papers in training set
Top 0.1%
1.7%
13
Nature Communications
4913 papers in training set
Top 54%
1.5%
14
PLOS ONE
4510 papers in training set
Top 58%
1.3%
15
JCI Insight
241 papers in training set
Top 5%
1.1%
16
PLOS Genetics
756 papers in training set
Top 12%
1.1%
17
Frontiers in Genetics
197 papers in training set
Top 7%
0.9%
18
Orphanet Journal of Rare Diseases
18 papers in training set
Top 0.5%
0.9%
19
Arthritis & Rheumatology
33 papers in training set
Top 0.4%
0.8%
20
Biomedicines
66 papers in training set
Top 3%
0.8%
21
International Journal of Biological Macromolecules
65 papers in training set
Top 3%
0.7%
22
PLOS Medicine
98 papers in training set
Top 5%
0.7%
23
npj Genomic Medicine
33 papers in training set
Top 1%
0.7%
24
Journal of Clinical Immunology
11 papers in training set
Top 0.1%
0.7%
25
Human Molecular Genetics
130 papers in training set
Top 4%
0.7%
26
PLOS Pathogens
721 papers in training set
Top 9%
0.7%
27
Clinical and Translational Medicine
30 papers in training set
Top 1%
0.7%
28
European Journal of Human Genetics
49 papers in training set
Top 1%
0.7%
29
Journal of Allergy and Clinical Immunology
25 papers in training set
Top 1.0%
0.6%
30
Journal of Medical Genetics
28 papers in training set
Top 0.6%
0.6%